KPV 10mg – 3ml Vial

Product Overview

KPV is a biologically active tripeptide fragment derived from residues 11–13 of alpha-melanocyte stimulating hormone (α-MSH). In controlled in-vitro and pre-clinical research systems, KPV is utilised to investigate:

• Cytokine signalling pathway modulation 
• NF-κB-associated inflammatory pathway research 
• Melanocortin receptor-related signalling mechanisms 
• Peptide-mediated immune response models 
• Cellular inflammatory cascade regulation 

Unlike the full-length α-MSH peptide, KPV represents a minimal active fragment studied for its targeted signalling characteristics in laboratory models.

Supplied in lyophilised form to preserve peptide stability and analytical integrity prior to reconstitution.

Key Features

• Synthetic α-MSH (11–13) fragment 
• Studied in inflammatory signalling pathway research 
• Investigated in cytokine modulation models 
• Associated with NF-κB pathway research 
• ≥99% purity (HPLC verified) 
• Lyophilised solid for enhanced stability 
• 10mg per sterile 3ml glass vial 

Product Specifications

• Product Name: KPV 
• Synonyms: Lys-Pro-Val Peptide; α-MSH (11–13) Fragment 
• Molecular Class: Synthetic tripeptide 
• Amino Acid Sequence (3-Letter Code):
  Lys-Pro-Val 
• Molecular Formula: C16H30N4O4 
• Molecular Weight: ~342.4 g/mol 
• CAS Number: 67727-97-3 
• Purity: ≥99% (HPLC) 
• Appearance: White to off-white lyophilised powder 
• Net Content: 10mg 
• Vial Size: 3ml sterile glass vial 
• Storage Form: Lyophilised peptide 
• Intended Use: Laboratory research only 

Handling & Storage Guidelines

Unreconstituted (Lyophilised) Storage:
Store at −20°C for long-term preservation. Short-term storage at 2–8°C is acceptable if intended for use within 1–3 months.

Reconstituted Storage:
After reconstitution, store at 2–8°C and use within 3–6 weeks. Stability may vary depending on solvent selection and handling conditions.

Avoid repeated freeze–thaw cycles. Protect from excessive agitation, heat, and direct light exposure.

Manufacturing & Quality

KPV is manufactured using precision solid-phase peptide synthesis (SPPS) under GMP-aligned laboratory standards.

Each batch undergoes:

• High Performance Liquid Chromatography (HPLC) purity verification 
• Mass spectrometry identity confirmation 
• Analytical quality control prior to release 
• Batch traceability and documentation procedures 

Products are released only after meeting strict internal quality specifications.

Legal & Safety Notice

This product is supplied strictly for laboratory research purposes only.

Not for human consumption.
Not for therapeutic, diagnostic, or veterinary use.
Not a licensed medicinal product in the United Kingdom.

The purchaser is responsible for ensuring full compliance with all applicable UK laws and regulations relating to research chemicals.